Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke.
Etiological assessment of stroke is essential for accurate treatment decisions and for secondary prevention of recurrence. There is evidence that interleukin-10 (IL-10) associates with ischemic stroke. The aim of this prospective study was to assess the levels of IL-10 in ischemic stroke with unknow...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4414573?pdf=render |
| _version_ | 1818925252140335104 |
|---|---|
| author | Otso Arponen Antti Muuronen Mikko Taina Petri Sipola Marja Hedman Pekka Jäkälä Ritva Vanninen Kari Pulkki Pirjo Mustonen |
| author_facet | Otso Arponen Antti Muuronen Mikko Taina Petri Sipola Marja Hedman Pekka Jäkälä Ritva Vanninen Kari Pulkki Pirjo Mustonen |
| author_sort | Otso Arponen |
| collection | DOAJ |
| description | Etiological assessment of stroke is essential for accurate treatment decisions and for secondary prevention of recurrence. There is evidence that interleukin-10 (IL-10) associates with ischemic stroke. The aim of this prospective study was to assess the levels of IL-10 in ischemic stroke with unknown or suspected cardiogenic etiology, and evaluate the correlation between IL-10 plasma concentration and the number of diagnosed high risk sources for cardioembolism.A total of 141 patients (97 males; mean age 61±11 years) with acute ischemic stroke with unknown etiology or suspected cardiogenic etiology other than known atrial fibrillation (AF) underwent imaging investigations to assess high risk sources for cardioembolic stroke established by the European Association of Echocardiography (EAE). IL-10 was measured on admission to the hospital and on a three month follow-up visit.Acute phase IL-10 concentration was higher in patients with EAE high risk sources, and correlated with their number (p<0.01). In patients with no risk sources (n = 104), the mean IL-10 concentration was 2.7±3.1 ng/L (range 0.3-16.3 ng/L), with one risk source (n = 26) 3.7±5.5 ng/L (0.3-23.6 ng/L), with two risk sources (n = 10) 7.0±10.0 ng/L (1.29-34.8 ng/L) and with three risk sources (n = 1) 37.2 ng/L. IL-10 level was not significantly associated with cerebral infarct volume, presence of previous or recent myocardial infarction, carotid/vertebral artery atherosclerosis, paroxysmal AF registered on 24-hour ECG Holter monitoring or given intravenous thrombolytic treatment.IL-10 plasma concentration correlates independently with the number of EAE cardioembolic risk sources in patients with acute stroke. IL-10 may have potential to improve differential diagnostics of stroke with unknown etiology. |
| first_indexed | 2024-12-20T02:38:16Z |
| format | Article |
| id | doaj.art-90627fe1c8334830afcd370b3e9f1b36 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-20T02:38:16Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-90627fe1c8334830afcd370b3e9f1b362022-12-21T19:56:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012091010.1371/journal.pone.0120910Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke.Otso ArponenAntti MuuronenMikko TainaPetri SipolaMarja HedmanPekka JäkäläRitva VanninenKari PulkkiPirjo MustonenEtiological assessment of stroke is essential for accurate treatment decisions and for secondary prevention of recurrence. There is evidence that interleukin-10 (IL-10) associates with ischemic stroke. The aim of this prospective study was to assess the levels of IL-10 in ischemic stroke with unknown or suspected cardiogenic etiology, and evaluate the correlation between IL-10 plasma concentration and the number of diagnosed high risk sources for cardioembolism.A total of 141 patients (97 males; mean age 61±11 years) with acute ischemic stroke with unknown etiology or suspected cardiogenic etiology other than known atrial fibrillation (AF) underwent imaging investigations to assess high risk sources for cardioembolic stroke established by the European Association of Echocardiography (EAE). IL-10 was measured on admission to the hospital and on a three month follow-up visit.Acute phase IL-10 concentration was higher in patients with EAE high risk sources, and correlated with their number (p<0.01). In patients with no risk sources (n = 104), the mean IL-10 concentration was 2.7±3.1 ng/L (range 0.3-16.3 ng/L), with one risk source (n = 26) 3.7±5.5 ng/L (0.3-23.6 ng/L), with two risk sources (n = 10) 7.0±10.0 ng/L (1.29-34.8 ng/L) and with three risk sources (n = 1) 37.2 ng/L. IL-10 level was not significantly associated with cerebral infarct volume, presence of previous or recent myocardial infarction, carotid/vertebral artery atherosclerosis, paroxysmal AF registered on 24-hour ECG Holter monitoring or given intravenous thrombolytic treatment.IL-10 plasma concentration correlates independently with the number of EAE cardioembolic risk sources in patients with acute stroke. IL-10 may have potential to improve differential diagnostics of stroke with unknown etiology.http://europepmc.org/articles/PMC4414573?pdf=render |
| spellingShingle | Otso Arponen Antti Muuronen Mikko Taina Petri Sipola Marja Hedman Pekka Jäkälä Ritva Vanninen Kari Pulkki Pirjo Mustonen Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke. PLoS ONE |
| title | Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke. |
| title_full | Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke. |
| title_fullStr | Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke. |
| title_full_unstemmed | Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke. |
| title_short | Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke. |
| title_sort | acute phase il 10 plasma concentration associates with the high risk sources of cardiogenic stroke |
| url | http://europepmc.org/articles/PMC4414573?pdf=render |
| work_keys_str_mv | AT otsoarponen acutephaseil10plasmaconcentrationassociateswiththehighrisksourcesofcardiogenicstroke AT anttimuuronen acutephaseil10plasmaconcentrationassociateswiththehighrisksourcesofcardiogenicstroke AT mikkotaina acutephaseil10plasmaconcentrationassociateswiththehighrisksourcesofcardiogenicstroke AT petrisipola acutephaseil10plasmaconcentrationassociateswiththehighrisksourcesofcardiogenicstroke AT marjahedman acutephaseil10plasmaconcentrationassociateswiththehighrisksourcesofcardiogenicstroke AT pekkajakala acutephaseil10plasmaconcentrationassociateswiththehighrisksourcesofcardiogenicstroke AT ritvavanninen acutephaseil10plasmaconcentrationassociateswiththehighrisksourcesofcardiogenicstroke AT karipulkki acutephaseil10plasmaconcentrationassociateswiththehighrisksourcesofcardiogenicstroke AT pirjomustonen acutephaseil10plasmaconcentrationassociateswiththehighrisksourcesofcardiogenicstroke |